eSScape

Efgartigimod PH20 SC in adult participants with systemic sclerosis. A phase 2, randomised, double-blind, placebo-controlled trial

Condition studied : Systemic sclerosis
Treatment : Injection of Efgartigimod or placebo
Sponsor : ARGX
Principal Investigator : Pr. Christian Jorgensen
: EU CT 2024-514539-67
Investigator
Pr. Christian Jorgensen
Director
Rechercher sur le site